Home > Healthcare & Medical Devices > Dermal Filler Market

Dermal Filler Market Size By Type (Biodegradable {Temporary Biodegradable, Semi-permanent Biodegradable}, Non-biodegradable), By Material Type (Hyaluronic Acid {HA}, Calcium Hydroxylapatite {CaHA}, Poly-L-lactic Acid, Polymethyl-methacrylate Microspheres {PMMA}), By Application (Facial Line Correction, Face Lift, Lip Enhancement), By End-use (Dermatology Clinics, Hospitals), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2028

  • Report ID: GMI3032
  • Base Year: 2021
  • Report Format: PDF

Industry trends

Dermal Filler Market size valued at USD 5 billion in 2021 and is poised to grow at a CAGR of over 9.6% between 2022 and 2028. Market growth is majorly driven by the increasing demand for minimally invasive aesthetic procedures, especially, in developed countries. Additionally, product development providing high patient satisfaction will positively impact the product demand during the forecast timeframe.
 

Dermal Filler Market Overview

Get more details on this report - Request Free Sample PDF
 

Continuous advancement in filler materials is expected to influence the market expansion in the coming years. The U.S. Food & Drug Administration (FDA) approved substantial number of products designed for specific facial areas that will allow dermatologists to offer targeted treatment to consumers. The filler is approved to correct medium to severe facial wrinkles and folds. In addition, recent developments including HA filler for subtle enhancement of lips that enhances lip definition without increase in size will further foster population preference towards dermal filler procedures.
 

Infrastructure development across developing nations will stimulate the product demand with expanded treatment accessibility

Expanding network of healthcare facilities providing advanced aesthetic treatments with improving infrastructure will support dermal filler market progression during the forecast period. In the recent years, a significant increase in number of facilities such as clinics, medical spas and rejuvenation centers was witnessed across the developed as well as developing nations. Thus, the rapid adoption of various non-invasive treatments offered by these facilities owing to the benefits including the cost-effectivity and shorter treatment duration will propel the industry growth. Furthermore, escalating number of skilled professionals such as dermatologists and plastic surgeons will further augment the industry expansion.
 

The pandemic has impacted aesthetic medicine and cosmetic dermatology to greater extent due to constraints on movement with lockdown in majority of regions across the globe. Moreover, slowdown of economies has resulted into minimized discretionary spending that has restricted the customers to undergo expensive cosmetic procedures. With decreasing number of cosmetic procedures, the industry witnessed limited demand for dermal filler. However, owing to high demand and subsequent decline in COVID-19 cases will help in market recovery.
 

Enhanced compatibility with minimized complications to impel the demand for biodegradable filler

Biodegradable dermal filler segment is anticipated to showcase 9.7% growth rate through 2028 led by the increasing product availability in the industry. The development in fillers have triggered neocollagenesis for more sustained aesthetic enhancements. Further, these agents reduce the risk of severe complications or adverse events. In addition, biodegradable filler can remove the necessity for allergy testing and are increasingly being developed by several players.
 

Reduced procedural complications with material advancements will benefit the product adoption rate

Hyaluronic acid (HA) segment held majority share in 2021. Increasing demand of hyaluronic acid injectables is predicted to influence the segment growth in the coming years. Hyaluronic acid dermal fillers are widely available with several manufacturers. Also, HA fillers are biocompatible and suitable with patient’s body. Further, the increasing procedural rate is attributed to lower risk of complications.
 

Enhanced ability of filler in facial line correction providing youthful appearance to boost the overall industry progression

Dermal Filler Market Size

Get more details on this report - Request Free Sample PDF
 

Facial line correction segment exceeded USD 2 billion in 2021. The use of facial filler has gained impetus due to their ability of smoothening frown lines between the eyebrows and nasolabial folds.  Increasing number of baby boomers across the globe seeking anti-aging and wrinkle treatment is estimated to accelerate the product demand. Further, the rising emphasis on facial appearance will be a high impacting factor for the segment expansion.
 

Rapid surge in acceptance of anti-aging treatments will positively impact the patient admission rate at clinics

Dermatology clinics segment crossed USD 2.5 billion in 2021. Dermatology clinics segment is slated to observe increased patient inflow owing to the growing acceptance of anti-aging treatment by elderly population in developed countries with expanding healthcare facilities. These clinics offer personalized and customized cosmetic treatments.
 

Higher usage of aesthetic procedures in the North America to spur the market demand

North America Dermal Filler Market

Get more details on this report - Request Free Sample PDF
 

North America dermal filler market captured over 35% of revenue share in 2021 on account of the growing adoption of facial procedures, including injectables. The region has registered significant trend shift from invasive to non-invasive treatments.
 

Moreover, increasing product availability with rising approvals by the U.S. FDA will broaden product accessibility in the region. Further, increasing population spending on aesthetic procedures will fortify the reginal growth during the forecast timeframe.
 

Key players are focusing on strategic acquisitions and collaborations to strengthen their market footprint

Notable key companies operating in the market are AbbVie (Allergan plc), Galderma and Merz Aesthetics. These market leaders are undertaking several growth strategies such as collaboration, partnership, merger and acquisitions to gain competitive edge and broaden their industry presence.
 

The dermal filler market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028 for the following segments:

Market, By Type

  • Biodegradable
    • Temporary biodegradable
    • Semi-permanent biodegradable
  • Non-biodegradable

Market, By Material type

  • Hyaluronic acid {HA}
  • Calcium Hydroxylapatite {CaHA}
  • Poly-L-lactic Acid
  • Polymethyl-methacrylate Microspheres {PMMA}
  • Others

Market, By Application

  • Facial Line Correction
  • Face Lift
  • Lip Enhancement
  • Others

Market, By End-use

  • Dermatology Clinics
  • Hospitals
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Spain
    • Italy
    • Russia
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE

 

Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

The global market size of dermal filler crossed USD 5 billion in 2021 and is expected to record a 9.6% CAGR up to 2028 due to the rising need for minimally invasive aesthetic procedures, especially in developed countries.

Dermal fillers are gel-like substances injected beneath the skin for restoring the lost volume, smooth lines, and softening creases, as well as enhancing facial contours.

Demand for biodegradable dermal fillers is projected to witness a growth rate of over 9.7% through 2028 owing to the rising product availability to cater to the escalating risks of severe complications or adverse events.

The dermatology clinics was worth USD 2.5 billion in 2021 and will grow with the expanding healthcare facilities and the rising acceptance of anti-aging treatment by elderly individuals in developed countries.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Published Date: Jan 2022
  • Companies covered: 12
  • Tables & Figures: 311
  • Countries covered: 19
  • Pages: 180

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount